Sep 4, 2024 · 25m · the-pitch
Will VCs Bet $1.5M on This AI That Prevents Hospital Falls?
Davina Desai · 8m spoken Elizabeth Yin · 2m spoken Mac Conwell · 2m spoken Josh Muccio · 2m spoken Cyan Banister · 1m spoken Ben Taft · 1m spoken
0:00 / 0:00
▶ Watch on YouTube →
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
Kinemetrix founder Davina Desai pitches her AI-driven clinical decision platform for preventing hospital falls on 'The Pitch,' securing $100,000 in venture backing while igniting a fierce investor debate over founder pragmatism versus venture-scale moonshots.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Josh holds 14.2% of the talking time here. How this is scored →
Josh as informed peer 5.6 Guest teaching 3.2 Guest disagreement 1.8 Josh pushing back 4.6
speaking balance: gold is Josh, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 15:53 Davina doubles down on pragmatic exit realism
Davina unapologetically stands behind her realistic exit strategy, questioning why a startup would engage in a destructive fight against dominant incumbents like Epic.
Hardest push from Josh ▶ 11:57 Cyan rejects the acquisition mindset and passesCyan directly refuses the founder's 5-year acquisition target, stating unequivocally that venture capital models require a 10-to-15-year moonshot horizon.
Biggest teaching moment ▶ 4:59 Educating the panel on fall risk drivers and staffing optimizationDavina corrects Cyan's assumption that higher fall risk creates additional nurse burden, explaining how behavioral monitoring and medication management tailor resources to clinical root causes.
Josh holds their own ▶ 12:47 Elizabeth drills into the three-year gap before first pilotsElizabeth challenges the startup's multi-year development cycle, probing whether the delay reflects slow enterprise execution or structural barriers.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Josh as informed peer | Guest teaching | Guest disagreement | Josh pushing back | Why |
|---|---|---|---|---|---|---|
| Davina Desai's Initial Pitch for Kinemetrix | 4 | 6 | 2 | 3 | Davina delivers a comprehensive pitch explaining clinical fall risks and hospital reimbursement dynamics. The investor panel asks baseline operational questions, and Davina educates them on why manual checklists fail and how dynamic EHR integration optimizes staffing rather than straining it. | |
| Financials, Distribution Strategy, and Mac's Early Offer | 5 | 3 | 1 | 1 | The conversation is highly collaborative as Davina explains contract values, pipeline metrics, and a distribution partnership with Avishore. Mac Conwell is impressed by the traction and immediately commits a minimum $50k check. | |
| Founder Background and the Exit Ambition Debate | 6 | 2 | 3 | 7 | When asked about long-term ambition, Davina pragmatically notes an acquisition in 5 years by a medical device player. Cyan Bannister firmly pushes back on this framing, stating venture capital requires moonshot outcomes, and steps out of the deal. | |
| Data Integrity, Development Journey, and Integration Timelines | 6 | 5 | 3 | 6 | Elizabeth presses Davina on why it took three years to reach a first pilot. Davina educates the panel on training models with three million real inpatient records instead of synthetic data, prompting Elizabeth to invest while Ben passes due to fund return math. | |
| The Investors' Post-Pitch Debate on Founder Archetypes | 7 | 0 | 0 | 6 | With the founder departed, the panel engages in a debate regarding pragmatic vs bombastic founder archetypes. Elizabeth and Mac argue that pragmatic operators can scale to billions, while Ben and Cyan defend rigid venture criteria. |
Statements from this episode (16)
Desai: Kinemetrix has 3 signed LOIs and 2 hospital contracts in process
“We have three signed letters of intent, as well as two large contracts and process with health systems that have some international presence as well.”
Desai: Kinemetrix has closed over $1.2M of its $1.5M round
“We are currently raising a 1.5 million dollar round from which we've already closed a little over 1.2 million dollars.”
Desai: Kinemetrix charges hospitals $480 per bed annually
“We charge hospitals a licensing fee, 480 dollars per bed per year. That's for the first module.”
Desai: Kinemetrix signed $1M pilot with second-largest Catholic health system
“So they're starting as a pilot in a region, but the average value for one of them is over five million each year. It's the second largest Catholic health system.”
Desai: AvaSure is reselling Kinemetrix across 1,100 hospital clients
“We also have a reseller agreement with Avishore. They're a remote video monitoring company. And they are actively selling kinemetrics to their 1100 hospital customers.”
Conwell: RareBreed will invest at least $50,000 in Kinemetrix
“So I, I'd be excited for Rare Breed to participate at minimum 50, maybe more, you know, going over due diligence and timing, but we got this.”
Desai: Kinemetrix will probably be acquired within five years
“Five years from now, I think we are probably going to be bought out by some medical device, either remote video monitoring, someone that wants that software solution that plugs in place for their product.”
Bannister passes on Kinemetrix over founder's early acquisition strategy
“The big thing for me actually was the answer that you gave about being acquired. I look for companies that are going to be around for 1015 years that are aiming for sort of a moonshot outcome, and that's the problem with venture. It doesn't mean that that's a …”
Desai: Synthetic healthcare data fails to mimic true patients
“A lot of solutions out there, especially in healthcare, use synthetic data. Synthetic data does not mimic a true patient.”
Kinemetrix built its platform using 3M inpatient records
“We use, built our platform using three million inpatient records.”
Yin: Founders generally only want to sell when startups struggle
“It, it's actually when things are not going that well, or there are issues, is when people want to sell.”
Taft: Venture capital optimizes for unrealistic moonshots over realistic outcomes
“Realistic is not the thing we're optimizing for. It's like the unrealistic things that Have some small probability of working, and you take that bet.”
Yin: Running a scaled company is easier than struggling at seed stage
“It's actually way easier to run a company with product market fit at a high level than it is to just hit your head against class on something that's not working at seed stage.”